Journal
JOURNAL OF ESSENTIAL OIL BEARING PLANTS
Volume 24, Issue 3, Pages 431-438Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/0972060X.2021.1942233
Keywords
Lavandula angustifolia; Lamiaceae; GC-MS; Linalool; Diabetes; alpha-Glucosidase
Categories
Funding
- King Khalid University, Abha, KSA
Ask authors/readers for more resources
The present study confirmed the antihyperglycemic activity of Lavandula angustifolia essential oil through inhibition of the alpha-glucosidase enzyme, suggesting its potential use in managing postprandial hyperglycemia in diabetic patients. The major chemical constituents identified in the essential oil include linalyl acetate, linalool, and trans-beta-caryophyllene.
Lavandula angustifolia is a major source of high-quality fragrance and extensively used in aromatherapy. Lavender is widely found in the Jammu and Kashmir region of India. The aim of the present study to determine chemical constituents present in the essential oil of L. angustifolia flowers by gas chromatography-mass spectrometry and to evaluate its antihyperglycemic activity via inhibition of the alpha-glucosidase enzyme. The chemical constituents of the essential of L. angustifolia flowers were determined by gas chromatography-mass spectrometry and its antihyperglycemic activity was evaluated by inhibition of the alpha-glucosidase enzyme. The Lavender flowers yielded 41 chemical constituents which constitute about 99.28 % of total essential oil and the major chemical constituents include linalyl acetate (39.28 %), linalool (26.76 %), trans-beta-caryophyllene (4.77 %), lavandulyl acetate (3.04 %) and 1,8-cineole (2.15 %). The essential oil from flowers of L. angustifolia showed concentration dependant alpha-glucosidase enzyme inhibition that varies from 24.27 +/- 2.18 to 64.04 +/- 1.29 % for concentration 31.25 to 1000 mu g/mL, respectively. The L. angustifolia essential oil with IC50 value 609.44 +/- 13.01 was found comparable with acarbose (IC50 value 526.5 +/- 12.19 mu g/mL) against the alpha-glucosidase enzyme. The study finding provides the basis for the possible use of L. angustifolia essential oil in the management of postprandial hyperglycemia in diabetic patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available